Associated Banc Corp cut its holdings in Cigna Group (NYSE:CI – Free Report) by 6.3% during the first quarter, Holdings Channel reports. The institutional investor owned 111,834 shares of the health services provider’s stock after selling 7,462 shares during the quarter. Associated Banc Corp’s holdings in Cigna Group were worth $29,832,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Cary Street Partners Investment Advisory LLC grew its stake in shares of Cigna Group by 11.0% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock worth $100,000 after purchasing an additional 36 shares during the period. OLD National Bancorp IN grew its holdings in shares of Cigna Group by 3.7% in the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock worth $284,000 after acquiring an additional 37 shares during the period. IHT Wealth Management LLC increased its stake in Cigna Group by 2.5% in the 4th quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock valued at $423,000 after purchasing an additional 38 shares in the last quarter. Whetstone Capital Advisors LLC raised its holdings in Cigna Group by 4.9% during the fourth quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider’s stock worth $228,000 after purchasing an additional 39 shares during the last quarter. Finally, CYBER HORNET ETFs LLC raised its holdings in Cigna Group by 5.3% during the fourth quarter. CYBER HORNET ETFs LLC now owns 801 shares of the health services provider’s stock worth $220,000 after purchasing an additional 40 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.
Insiders Place Their Bets
In related news, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the transaction, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. This trade represents a 85.46% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.60% of the company’s stock.
Cigna Group Price Performance
Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. During the same period in the prior year, the company earned $6.74 EPS. Cigna Group’s revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, analysts forecast that Cigna Group will post 30.39 earnings per share for the current fiscal year.
Cigna Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were paid a dividend of $1.56 per share. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.
Analysts Set New Price Targets
Several research analysts have recently issued reports on the company. Mizuho lifted their price target on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Morgan Stanley lifted their target price on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 20th. Barclays lowered shares of Cigna Group from an “overweight” rating to an “equal weight” rating and dropped their price target for the stock from $310.00 to $304.00 in a research report on Tuesday, May 26th. Wolfe Research reissued an “outperform” rating and issued a $315.00 price objective on shares of Cigna Group in a research report on Tuesday, June 16th. Finally, Royal Bank Of Canada raised their price objective on Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $338.80.
Read Our Latest Research Report on CI
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Recommended Stories
- Five stocks we like better than Cigna Group
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
- Why “Big Short” Investor Michael Burry Sees Upside in Beaten-Down Sportbook Stocks
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
